Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

German Bou

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|March 15, 2017
WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk ClonesBartolome Moya, Isabel M Barcelo, Sachin Bhagwat, et al.
Plos One|March 23, 2017
Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzymeMaría López, Celia Mayer, Laura Fernández-García, et al.
Viruses|October 21, 2020
Viral Related Tools against SARS-CoV-2Laura Fernandez-Garcia, Olga Pacios, Mónica González-Bardanca, et al.
Emerging Infectious Diseases|August 23, 2005
Williamsia muralis pulmonary infectionMaria del Mar Tomas, Rita Moure, Juan Antonio Saez Nieto, et al.
Antibiotics (Basel, Switzerland)|February 12, 2020
Strategies to Combat Multidrug-Resistant and Persistent Infectious DiseasesOlga Pacios, Lucia Blasco, Inès Bleriot, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2017
Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical IsolatesBartolome Moya, Isabel M Barcelo, Sachin Bhagwat, et al.
Journal of Clinical Microbiology|September 15, 2004
Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporinsMonica Cartelle, Maria del Mar Tomas, Sonia Pertega, et al.
Microbiology Spectrum|February 9, 2022
Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of <i>bla</i><sub>OXA-24/40</sub> and Genetic Characterization of the Transmission Mechanism between Acinetobacter Genomic SpeciesCristina Lasarte-Monterrubio, Paula Guijarro-Sánchez, Alba Bellés, et al.
Infection Control and Hospital Epidemiology|November 3, 2004
Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitalsJesús Rodríguez-Baño, Jose M Cisneros, Felipe Fernández-Cuenca, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2016
Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumanniiMarta Martínez-Guitián, Juan C Vázquez-Ucha, Joshua Odingo, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|March 15, 2017
WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk ClonesBartolome Moya, Isabel M Barcelo, Sachin Bhagwat, et al.
Plos One|March 23, 2017
Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzymeMaría López, Celia Mayer, Laura Fernández-García, et al.
Viruses|October 21, 2020
Viral Related Tools against SARS-CoV-2Laura Fernandez-Garcia, Olga Pacios, Mónica González-Bardanca, et al.
Emerging Infectious Diseases|August 23, 2005
Williamsia muralis pulmonary infectionMaria del Mar Tomas, Rita Moure, Juan Antonio Saez Nieto, et al.
Antibiotics (Basel, Switzerland)|February 12, 2020
Strategies to Combat Multidrug-Resistant and Persistent Infectious DiseasesOlga Pacios, Lucia Blasco, Inès Bleriot, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2017
Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical IsolatesBartolome Moya, Isabel M Barcelo, Sachin Bhagwat, et al.
Journal of Clinical Microbiology|September 15, 2004
Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporinsMonica Cartelle, Maria del Mar Tomas, Sonia Pertega, et al.
Microbiology Spectrum|February 9, 2022
Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of <i>bla</i><sub>OXA-24/40</sub> and Genetic Characterization of the Transmission Mechanism between Acinetobacter Genomic SpeciesCristina Lasarte-Monterrubio, Paula Guijarro-Sánchez, Alba Bellés, et al.
Infection Control and Hospital Epidemiology|November 3, 2004
Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitalsJesús Rodríguez-Baño, Jose M Cisneros, Felipe Fernández-Cuenca, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2016
Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumanniiMarta Martínez-Guitián, Juan C Vázquez-Ucha, Joshua Odingo, et al.
Pageof 7